Theravance Biopharma Inc.

Theravance Biopharma Inc. annual/quarterly operating income history and growth rate from 2012 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.

• Theravance Biopharma Inc. operating income for the quarter ending March 31, 2026 was -9.5 M, a 34.30% decrease year-over-year.
• Theravance Biopharma Inc. operating income for the twelve months ending March 31, 2026 was -33.1 M, a 28.84% decrease year-over-year.
• Theravance Biopharma Inc. annual operating income for 2025 was -3.6 M, a 92.33% decrease from 2024.
• Theravance Biopharma Inc. annual operating income for 2024 was -46.9 M, a 16.21% decrease from 2023.
• Theravance Biopharma Inc. annual operating income for 2023 was -56.0 M, a 39.06% decrease from 2022.
• Theravance Biopharma Inc. annual operating income for 2022 was -92.0 M.